View Single Post
Old 03-14-2010, 11:26 AM   #13
Hopeful
Senior Member
 
Join Date: Aug 2006
Posts: 3,380
Re: Risk of Recurrent Disease in HER2-Positive Patients

Jean,

I think the neratinib trial is sort of in the same niche as a "herceptin tune up." The concept is to give it to women who have had herceptin and are now NED, to see if it prevents recurrence. I think the feeling is that since Neratinib is an oral med rather than an infusion, it would be easier for the patients.

Becky,

I noticed your new photo too and think you look great!

Hopeful
Hopeful is offline   Reply With Quote